FXR1 regulates vascular smooth muscle cell cytoskeleton, VSMC contractility, and blood pressure by multiple mechanisms.

[1]  K. Rottner,et al.  WAVE regulatory complex , 2021, Current Biology.

[2]  S. Eguchi,et al.  Targeting Mitochondrial Fission as a Potential Therapeutic for Abdominal Aortic Aneurysm. , 2020, Cardiovascular research.

[3]  Shanshan Liu,et al.  HuR (Human Antigen R) Regulates the Contraction of Vascular Smooth Muscle and Maintains Blood Pressure , 2020, Arteriosclerosis, thrombosis, and vascular biology.

[4]  K. Rottner,et al.  Actin dynamics in cell migration , 2019, Essays in biochemistry.

[5]  K. Moore,et al.  Regulation of Stress Granule Formation by Inflammation, Vascular Injury, and Atherosclerosis. , 2019, Arteriosclerosis, thrombosis, and vascular biology.

[6]  M. Ray,et al.  RNA stability protein ILF3 mediates cytokine‐induced angiogenesis , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  Michael J. Sweredoski,et al.  FXR1 Is an IL-19-Responsive RNA-Binding Protein that Destabilizes Pro-inflammatory Transcripts in Vascular Smooth Muscle Cells. , 2018, Cell reports.

[8]  S. Gunst,et al.  Rho kinase collaborates with p21‐activated kinase to regulate actin polymerization and contraction in airway smooth muscle , 2018, The Journal of physiology.

[9]  Laurel A. Grisanti,et al.  Genetic Deletion of IL-19 (Interleukin-19) Exacerbates Atherogenesis in Il19−/−×Ldlr−/− Double Knockout Mice by Dysregulation of mRNA Stability Protein HuR (Human Antigen R) , 2018, Arteriosclerosis, thrombosis, and vascular biology.

[10]  W. Ge,et al.  The tandem Agenet domain of fragile X mental retardation protein interacts with FUS , 2017, Scientific Reports.

[11]  S. Eguchi,et al.  Induction of MiR133a expression by IL-19 targets LDLRAP1 and reduces oxLDL uptake in VSMC. , 2017, Journal of molecular and cellular cardiology.

[12]  K. Moore,et al.  IL-19 Halts Progression of Atherosclerotic Plaque, Polarizes, and Increases Cholesterol Uptake and Efflux in Macrophages. , 2016, The American journal of pathology.

[13]  A. Duggirala,et al.  cAMP-induced actin cytoskeleton remodelling inhibits MKL1-dependent expression of the chemotactic and pro-proliferative factor, CCN1 , 2015, Journal of molecular and cellular cardiology.

[14]  B. Bardoni,et al.  CYFIP family proteins between autism and intellectual disability: links with Fragile X syndrome , 2014, Front. Cell. Neurosci..

[15]  M. Kessels,et al.  FMRP regulates actin filament organization via the armadillo protein p0071 , 2013, RNA.

[16]  Peter J Hume,et al.  Arf6 coordinates actin assembly through the WAVE complex, a mechanism usurped by Salmonella to invade host cells , 2013, Proceedings of the National Academy of Sciences.

[17]  Linnaea E. Ostroff,et al.  CYFIP1 Coordinates mRNA Translation and Cytoskeleton Remodeling to Ensure Proper Dendritic Spine Formation , 2013, Neuron.

[18]  M. Goumans,et al.  Quaking, an RNA-Binding Protein, Is a Critical Regulator of Vascular Smooth Muscle Cell Phenotype , 2013, Circulation research.

[19]  Amber L. Couzens,et al.  The CRAPome: a Contaminant Repository for Affinity Purification Mass Spectrometry Data , 2013, Nature Methods.

[20]  S. Gunst,et al.  The Small GTPase RhoA Regulates the Contraction of Smooth Muscle Tissues by Catalyzing the Assembly of Cytoskeletal Signaling Complexes at Membrane Adhesion Sites* , 2012, The Journal of Biological Chemistry.

[21]  L. Maquat,et al.  Regulation of cytoplasmic mRNA decay , 2012, Nature Reviews Genetics.

[22]  Michael J. Sweredoski,et al.  Protein Interaction Profiling of the p97 Adaptor UBXD1 Points to a Role for the Complex in Modulating ERGIC-53 Trafficking* , 2012, Molecular & Cellular Proteomics.

[23]  S. Ceman,et al.  Fragile X family members have important and non-overlapping functions , 2011, Biomolecular concepts.

[24]  O. Jensen,et al.  WAVE regulatory complex activation by cooperating GTPases Arf and Rac1 , 2011, Proceedings of the National Academy of Sciences.

[25]  D. Licatalosi,et al.  FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism , 2011, Cell.

[26]  M. Mann,et al.  Andromeda: a peptide search engine integrated into the MaxQuant environment. , 2011, Journal of proteome research.

[27]  Surbhi Jain,et al.  The Anti‐Inflammatory Cytokine Interleukin‐19 Inhibits Smooth Muscle Cell Migration and Activation of Cytoskeletal Regulators of VSMC Motility , 2011, American journal of physiology. Cell physiology.

[28]  Zbyszek Otwinowski,et al.  Structure and Control of the Actin Regulatory WAVE Complex , 2010, Nature.

[29]  P. Pacaud,et al.  The role of Rho protein signaling in hypertension , 2010, Nature Reviews Cardiology.

[30]  M. Autieri,et al.  Il-19 reduces VSMC activation by regulation of mRNA regulatory factor HuR and reduction of mRNA stability. , 2010, Journal of molecular and cellular cardiology.

[31]  K. Khalili,et al.  RNA-binding protein HuR regulates RGS4 mRNA stability in rabbit colonic smooth muscle cells. , 2010, American journal of physiology. Cell physiology.

[32]  J. W. Rush,et al.  RhoA-Rho kinase signaling mediates endothelium- and endoperoxide-dependent contractile activities characteristic of hypertensive vascular dysfunction. , 2010, American journal of physiology. Heart and circulatory physiology.

[33]  R. Torres,et al.  The Rho exchange factor Arhgef1 mediates the effects of angiotensin II on vascular tone and blood pressure , 2010, Nature Medicine.

[34]  M. Mann,et al.  MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification , 2008, Nature Biotechnology.

[35]  S. Gunst,et al.  Cytoskeletal remodeling in differentiated vascular smooth muscle is actin isoform dependent and stimulus dependent. , 2008, American journal of physiology. Cell physiology.

[36]  S. Gunst,et al.  Actin cytoskeletal dynamics in smooth muscle: a new paradigm for the regulation of smooth muscle contraction. , 2008, American journal of physiology. Cell physiology.

[37]  D. Tang,et al.  Physiologic Properties and Regulation of the Actin Cytoskeleton in Vascular Smooth Muscle , 2008, Journal of cardiovascular pharmacology and therapeutics.

[38]  É. Khandjian,et al.  Fragile X related protein 1 isoforms differentially modulate the affinity of fragile X mental retardation protein for G-quartet RNA structure , 2006, Nucleic acids research.

[39]  Niels Volkmann,et al.  Mechanism of Filament Nucleation and Branch Stability Revealed by the Structure of the Arp2/3 Complex at Actin Branch Junctions , 2005, PLoS biology.

[40]  J. Mandel,et al.  FMRP interferes with the Rac1 pathway and controls actin cytoskeleton dynamics in murine fibroblasts. , 2005, Human molecular genetics.

[41]  É. Khandjian,et al.  Fragile X-related Protein FXR1P Regulates Proinflammatory Cytokine Tumor Necrosis Factor Expression at the Post-transcriptional Level* , 2005, Journal of Biological Chemistry.

[42]  D. Nelson,et al.  Fxr1 knockout mice show a striated muscle phenotype: implications for Fxr1p function in vivo. , 2004, Human molecular genetics.

[43]  D. Hartshorne,et al.  Activation of RhoA and Inhibition of Myosin Phosphatase as Important Components in Hypertension in Vascular Smooth Muscle , 2003, Circulation research.

[44]  Sebastian Maurer-Stroh,et al.  The Tudor domain 'Royal Family': Tudor, plant Agenet, Chromo, PWWP and MBT domains. , 2003, Trends in biochemical sciences.

[45]  J. Darnell,et al.  Microarray Identification of FMRP-Associated Brain mRNAs and Altered mRNA Translational Profiles in Fragile X Syndrome , 2001, Cell.

[46]  J. Mandel,et al.  The Fragile X mental retardation protein , 2001, Brain Research Bulletin.

[47]  J. Mandel,et al.  A highly conserved protein family interacting with the fragile X mental retardation protein (FMRP) and displaying selective interactions with FMRP-related proteins FXR1P and FXR2P , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[48]  A. Takeshita,et al.  Involvement of Rho-kinase in hypertensive vascular disease: a novel therapeutic target in hypertension. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[49]  T. Gibson,et al.  Dissecting FMR1, the protein responsible for fragile X syndrome, in its structural and functional domains. , 1999, RNA.

[50]  Alun D. Hughes,et al.  Platelet-derived growth factor (PDGF): actions and mechanisms in vascular smooth muscle. , 1996, General pharmacology.

[51]  A. Poustka,et al.  Highly conserved 3' UTR and expression pattern of FXR1 points to a divergent gene regulation of FXR1 and FMR1. , 1995, Human molecular genetics.

[52]  I. Zachary,et al.  Signalling mechanisms in the regulation of vascular cell migration. , 1995, Cardiovascular research.

[53]  J. Mandel,et al.  A heterogeneous set of FMR1 proteins is widely distributed in mouse tissues and is modulated in cell culture. , 1995, Human molecular genetics.

[54]  J. Mandel,et al.  The FMR–1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation , 1993, Nature Genetics.

[55]  OUP accepted manuscript , 2021, Nucleic Acids Research.

[56]  D. Arveiler,et al.  Residual cardiovascular risk in treated hypertension and hyperlipidaemia: the PRIME Study , 2010, Journal of Human Hypertension.

[57]  Stefan Offermanns,et al.  G12-G13–LARG–mediated signaling in vascular smooth muscle is required for salt-induced hypertension , 2008, Nature Medicine.

[58]  P. Ngo,et al.  Collagen gel contraction assay. , 2006, Methods in molecular biology.

[59]  V. V. van Hinsbergh,et al.  Cytoskeletal effects of rho-like small guanine nucleotide-binding proteins in the vascular system. , 2001, Arteriosclerosis, thrombosis, and vascular biology.